Rigel Pharmaceuticals
RIGL
96 hedge funds and large institutions have $172M invested in Rigel Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 41 reducing their positions, and 18 closing their positions.
13% more capital invested
Capital invested by funds: $153M → $172M (+$19.7M)
8% less funds holding
Funds holding: 104 → 96 (-8)
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
44% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 41
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.2M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.55M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.54M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.48M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.16M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
101
Tower Research Capital (TRC)
New York
| – | -$44K | -2,283 | Closed |
|
|
SCA
102
Secor Capital Advisors
New York
| – | -$33K | -1,724 | Closed |
|
103
Citadel Advisors
Miami,
Florida
| – | -$33K | -1,716 | Closed |
|
|
PL
104
Parkwood LLC
Cleveland,
Ohio
| – | -$30K | -1,536 | Closed |
|
105
M&T Bank
Buffalo,
New York
| – | -$23K | -1,156 | Closed |
|
106
BNP Paribas Financial Markets
Paris,
France
| – | -$10.1K | -520 | Closed |
|
107
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$9K | -445 | Closed |
|
108
Teacher Retirement System of Texas
Austin,
Texas
| – | -$6K | -286 | Closed |
|
109
Creative Planning
Overland Park,
Kansas
| – | -$1K | -64 | Closed |
|
110
Simplex Trading
Chicago,
Illinois
| – | +$20 | +1 | New |
|
111
Group One Trading
Chicago,
Illinois
| – | +$101 | +5 | New |
|
RIGL Hedge Fund Activity: Q4 2014 in Review
96 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q4 2014, worth a combined $172M — up 13% from $153M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of RIGL and 12 opened new positions — a net loss of 6 holders — while 41 trimmed existing stakes and 23 added.
The largest buyer was Broadfin Capital, adding an estimated $5.06M. The largest seller was Millennium Management, cutting an estimated $2.2M.
- 96 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q4 2014, down from 104 in Q3 2014.
- Funds reported $172M of Rigel Pharmaceuticals stock for Q4 2014, up 13% quarter-over-quarter.
- 12 funds opened new Rigel Pharmaceuticals positions in Q4 2014 and 18 closed out, a net change of -6 holders.
- The largest Rigel Pharmaceuticals buyer in Q4 2014 was Broadfin Capital, an estimated $5.06M added.
- The largest Rigel Pharmaceuticals seller in Q4 2014 was Millennium Management, an estimated $2.2M sold.
Based on aggregated 13F filings for Q4 2014.